Copyright
©The Author(s) 2000.
World J Gastroenterol. Apr 15, 2000; 6(2): 244-247
Published online Apr 15, 2000. doi: 10.3748/wjg.v6.i2.244
Published online Apr 15, 2000. doi: 10.3748/wjg.v6.i2.244
Table 1 The quantity of apoptotic bodies in hepatic and renal tissues of each group (mean ± SD, number/× 400)
Renal ischemia-reperfusion group | Hepatic ischemia-reperfusion group | |||
n | Quantity of apoptotic bodies | n | Quantity of apoptotic bodies | |
Control group | 5 | 9.0 ± 3.2 | 5 | 8.5 ± 3.4 |
Non-treatment group | ||||
1 h of reperfusion | 5 | 23.4 ± 2.9ab | 5 | 18.3 ± 3.5ab |
3 h of reperfusion | 5 | 131.6 ± 7.6ab | 5 | 74.9 ± 6.8ab |
6 h of reperfusion | 5 | 209.6 ± 8.4ab | 5 | 94.6 ± 8.1ab |
24 h of reperfusion | 5 | 427.8 ± 37.1ab | 5 | 397.4 ± 40.2ab |
mAb treatment group | 20 | 13.0 ± 3.9a | 20 | 13.1 ± 3.7a |
- Citation: Wu P, Li X, Zhou T, Zhang MJ, Chen JL, Wang WM, Chen N, Dong DC. Role of P-selectin and anti-P-selectin monoclonal antibody in apoptosis during hepatic/renal ischemia-reperfusion injury. World J Gastroenterol 2000; 6(2): 244-247
- URL: https://www.wjgnet.com/1007-9327/full/v6/i2/244.htm
- DOI: https://dx.doi.org/10.3748/wjg.v6.i2.244